AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

Source

World

Gold, silver prices fall after CME raises precious metals margins — again

December 31, 2025

One kilogram and a five hundred gram gold bars next to one kilogram silver bars at The Vaults Group gold dealers arranged in Barcelona, Spain, on Monday, April 28, 2025. Bloomberg | Bloomberg | Getty Images Gold and silver prices lost ground on Wednesday as investors booked profits after a historic annual rally and exchange […]

World

Retail investors close out one of their best years ever. How they beat Wall Street at their own game

December 31, 2025

A graph displaying the Apple stock price on a smartphone app. Jaap Arriens | Nurphoto | Getty Images Retail investors have had a gangbuster year in 2025. Mom-and-pop investors bought the dip at key points this year, providing strong returns as the market climbed to all-time highs. Once thought of as unsophisticated and easily duped, […]

World

Champagne sales surge at New Year — but labor abuses and tariffs have clouded the industry

December 31, 2025

Bulgarian grape harvesters work in the vineyards of Chateau de Meursault in Meursault, in the Burgundy region of central-eastern France, on August 26, 2025. (Photo by ARNAUD FINISTRE / AFP) (Photo by ARNAUD FINISTRE/AFP via Getty Images) Arnaud Finistre | Afp | Getty Images It’ll come as no surprise that sales of Champagne peak in […]